Search research articles
Contact Us
Filters
Showing results (11-20 of 190) with videos related to
Page
of 19
Sort By:
Seminars in Thoracic and Cardiovascular Surgery
|
August 18, 2005
Role of chemotherapy in the management of advanced thymic tumors
Tracey L Evans, Thomas J Lynch
The Oncologist
|
April 10, 2009
Combined inhibition of the VEGFR and EGFR signaling pathways in the treatment of NSCLC
Nathan A Pennell, Thomas J Lynch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 23, 2003
Aggressive treatment for the fit elderly with non-small-cell lung cancer? Yes!
Lecia V Sequist, Thomas J Lynch
The New England Journal of Medicine
|
February 21, 2007
CT screening for lung cancer
Andrew J Yee, Thomas J Lynch
Clinical Lung Cancer
|
October 8, 2009
Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer
Inga T Lennes, Thomas J Lynch
Clinical Lung Cancer
|
December 10, 2003
A phase II study of the immunotoxin N901-blocked ricin in small-cell lung cancer
Panos Fidias, Michael Grossbard, Thomas J Lynch
Advances in Experimental Medicine and Biology
|
September 6, 2019
Heterogeneity of Pulmonary Stem Cells
Thomas J Lynch, Vitaly Ievlev, Kalpaj R Parekh
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 13, 2021
AAV-mediated gene editing lights up the lung
Ziying Yan, Thomas J Lynch, John F Engelhardt
The Oncologist
|
June 1, 2004
Too old to care?
Richard T Penson, Kristy J Daniels, Thomas J Lynch
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2005
Epidermal growth factor receptor mutations in non-small cell lung cancer: predicting clinical response to kinase inhibitors
Lecia V Sequist, Daniel A Haber, Thomas J Lynch
Page
of 19
Search research articles
Search
Showing results (11-20 of 190) with videos related to
Sort By:
Page
of 19
Seminars in Thoracic and Cardiovascular Surgery
|
August 18, 2005
Role of chemotherapy in the management of advanced thymic tumors
Tracey L Evans, Thomas J Lynch
The Oncologist
|
April 10, 2009
Combined inhibition of the VEGFR and EGFR signaling pathways in the treatment of NSCLC
Nathan A Pennell, Thomas J Lynch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 23, 2003
Aggressive treatment for the fit elderly with non-small-cell lung cancer? Yes!
Lecia V Sequist, Thomas J Lynch
The New England Journal of Medicine
|
February 21, 2007
CT screening for lung cancer
Andrew J Yee, Thomas J Lynch
Clinical Lung Cancer
|
October 8, 2009
Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer
Inga T Lennes, Thomas J Lynch
Clinical Lung Cancer
|
December 10, 2003
A phase II study of the immunotoxin N901-blocked ricin in small-cell lung cancer
Panos Fidias, Michael Grossbard, Thomas J Lynch
Advances in Experimental Medicine and Biology
|
September 6, 2019
Heterogeneity of Pulmonary Stem Cells
Thomas J Lynch, Vitaly Ievlev, Kalpaj R Parekh
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 13, 2021
AAV-mediated gene editing lights up the lung
Ziying Yan, Thomas J Lynch, John F Engelhardt
The Oncologist
|
June 1, 2004
Too old to care?
Richard T Penson, Kristy J Daniels, Thomas J Lynch
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2005
Epidermal growth factor receptor mutations in non-small cell lung cancer: predicting clinical response to kinase inhibitors
Lecia V Sequist, Daniel A Haber, Thomas J Lynch
Page
of 19